Biogen hires former Sanofi head Viehbacher as CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St falls as oil ticks up, yields rise ahead of US-China summit
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil holds near two-week lows while diesel cracks hit record
Biogen (BIIB) new CEO could be 'just what BIIB needs'
November 10, 2022 1:04 PM ESTBiogen (NASDAQ: BIIB) announced that the former CEO of Sanofi, Christopher Viehbacher, will take over as its President, CEO, and member of the Board of Directors effective on November 14.
Following the announcement, Cowen analyst Phil Nadeau told investors in a note that although his tenure at Sanofi ended abruptly, a strong CEO personality aligned with... More
